Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Petit · SciRah

Researcher profile · Semantic Scholar

T. Petit

Share profile

T. Petit — researcher profile on SciRah

h-index: 41
Works: 206
Citations: 6,299

Most-cited papers

Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort.
E. Gobbini, M. Ezzalfani, V. Diéras, T. Bachelot +24 more
2018European Journal of Cancer270 citations
Semantic Scholar
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort
A. Darlix, G. Louvel, J. Fraisse, W. Jacot +22 more
2019British Journal of Cancer219 citations Open access
Semantic Scholar
Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
A. Ferreira, A. di Meglio, B. Pistilli, A. Gbenou +21 more
2019Annals of Oncology211 citations Open access
Semantic Scholar
Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016.
É. Deluche, A. Antoine, T. Bachelot, A. Lardy-Cléaud +23 more
2020European Journal of Cancer176 citations
Semantic Scholar
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
J. Pfisterer, C. Shannon, K. Baumann, J. Rau +27 more
2020The Lancet Oncology145 citations Open access
Semantic Scholar
Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort
T. Grinda, A. Antoine, W. Jacot, C. Blaye +23 more
2021ESMO Open137 citations Open access
Semantic Scholar
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
X. Pivot, G. Romieu, M. Debled, J. Pierga +330 more
2019The Lancet117 citations Open access
Semantic Scholar
Abstract PD8-02: Trastuzumab deruxtecan (T-DXd) for advanced breast cancer patients (ABC), regardless HER2 status: A phase II study with biomarkers analysis (DAISY)
V. Diéras, E. Deluche, A. Lusque, B. Pistilli +18 more
2022Cancer Research84 citations
Semantic Scholar
Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study
Elisé G. Kaboré, C. Guenancia, I. Vaz-Luis, A. di Meglio +16 more
2019PLoS Medicine64 citations Open access
Semantic Scholar
Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3‐arm randomized trial
M. Dos Santos, I. Hardy-Léger, O. Rigal, I. Licaj +15 more
2020Cancer59 citations Open access
Semantic Scholar
Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis
E. Pons-Tostivint, Y. Kirova, A. Lusque, M. Campone +22 more
2018Annals of Surgical Oncology56 citations
Semantic Scholar
Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort.
D. Pasquier, A. Darlix, G. Louvel, J. Fraisse +23 more
2019European Journal of Cancer51 citations Open access
Semantic Scholar
Multicenter evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic
A. Bizot, M. Karimi, E. Rassy, P. Heudel +19 more
2021British Journal of Cancer50 citations Open access
Semantic Scholar
Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort
S. Frank, M. Carton, C. Dubot, M. Campone +20 more
2020Breast46 citations Open access
Semantic Scholar
Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database
M. Carausu, M. Carton, A. Darlix, D. Pasquier +19 more
2021ESMO Open44 citations Open access
Semantic Scholar
Impact of body mass index on overall survival in patients with metastatic breast cancer
K. Saleh, M. Carton, V. Diéras, P. Heudel +22 more
2020Breast41 citations Open access
Semantic Scholar
Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort.
T. Grinda, A. Antoine, W. Jacot, P. Cottu +21 more
2023European Journal of Cancer34 citations Open access
Semantic Scholar
Real‐life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program
W. Jacot, P. Heudel, J. Fraisse, S. Gourgou +19 more
2019International Journal of Cancer34 citations Open access
Semantic Scholar
Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France
Ombline de Calbiac, A. Lusque, A. Mailliez, T. Bachelot +16 more
2022JAMA Network Open33 citations Open access
Semantic Scholar
Carboplatin/pegylated liposomal doxorubicin/bevacizumab (CD-BEV) vs. carboplatin/gemcitabine/bevacizumab (CG-BEV) in patients with recurrent ovarian cancer: A prospective randomized phase III ENGOT/GCIG-Intergroup study (AGO study group, AGO-Austria, ANZGOG, GINECO, SGCTG).
J. Pfisterer, A. Dean, K. Baumann, J. Rau +16 more
2018Annals of Oncology33 citations Open access
Semantic Scholar
Unhealthy behaviors after breast cancer: Capitalizing on a teachable moment to promote lifestyle improvements
A. di Meglio, A. Gbenou, E. Martin, B. Pistilli +22 more
2021Cancer32 citations Open access
Semantic Scholar
Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis.
E. Pons-Tostivint, Y. Kirova, A. Lusque, M. Campone +22 more
2020Radiotherapy and Oncology32 citations
Semantic Scholar
Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program
M. Bertho, J. Fraisse, A. Patsouris, P. Cottu +20 more
2021Therapeutic Advances in Medical Oncology28 citations Open access
Semantic Scholar
Efficacy of anthracycline/taxane‐based neo‐adjuvant chemotherapy on triple‐negative breast cancer in BRCA1/BRCA2 mutation carriers
L. Bignon, J. Fricker, C. Noguès, E. Mouret-Fourme +11 more
2018The Breast Journal27 citations Open access
Semantic Scholar
Impact of lobular versus ductal histology on overall survival in metastatic breast cancer: a French retrospective multicentre cohort study.
F. Dalenc, A. Lusque, T. de la Motte Rouge, B. Pistilli +17 more
2022European Journal of Cancer24 citations
Semantic Scholar
Early Locoregional Breast Surgery and Survival in de novo Metastatic Breast Cancer in the Multicenter National ESME Cohort
J. Hotton, A. Lusque, L. Leufflen, M. Campone +20 more
2021Annals of Surgery23 citations
Semantic Scholar
Clinical activity of MCLA-128 (zenocutuzumab), trastuzumab, and vinorelbine in HER2 amplified metastatic breast cancer (MBC) patients (pts) who had progressed on anti-HER2 ADCs.
E. Hamilton, T. Petit, B. Pistilli, A. Gonçalves +16 more
202023 citations
Semantic Scholar
Abstract GS3-05: Fulvestrant-palbociclib vs continuing aromatase inhibitor-palbociclib upon detection of circulating ESR1 mutation in HR+ HER2- metastatic breast cancer patients: Results of PADA-1, a UCBG-GINECO randomized phase 3 trial
F. Bidard, A. Hardy-Bessard, T. Bachelot, J. Pierga +24 more
2022Cancer Research21 citations
Semantic Scholar
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database
C. Courtinard, S. Gourgou, W. Jacot, M. Carton +20 more
2023BMC Medicine16 citations Open access
Semantic Scholar
Persistent taxane‐induced neuropathy in elderly patients treated for localized breast cancer
L. Pabst, M. Velten, C. Fischbach, M. Kalish +3 more
2020The Breast Journal16 citations Open access
Semantic Scholar
Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study
Hélène François-Martin, A. Lardy-Cléaud, B. Pistilli, C. Lévy +19 more
2023Cancers11 citations Open access
Semantic Scholar
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real‐world database
A. Mailliez, V. D'Hondt, A. Lusque, O. Caron +18 more
2022International Journal of Cancer11 citations Open access
Semantic Scholar
Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients
H. Carinato, M. Burgy, Régine Ferry, C. Fischbach +14 more
2021Frontiers in Oncology11 citations Open access
Semantic Scholar
PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Paclitaxel Regimen in HER2-Negative Inflammatory Breast Cancer
A. Bertucci, F. Bertucci, C. Zemmour, F. Lerebours +7 more
2020Frontiers in Oncology11 citations Open access
Semantic Scholar
Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database
M. Annonay, L. Gauquelin, R. Geiss, M. Ung +22 more
2021Breast10 citations Open access
Semantic Scholar
Fulvestrant and palbociclib combination in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer patients
H. Herrscher, M. Velten, J. Leblanc, M. Kalish-Weindling +4 more
2019Breast Cancer Research and Treatment10 citations
Semantic Scholar
Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational study
A. Vasseur, M. Carton, S. Guiu, P. Augereau +18 more
2022Breast9 citations Open access
Semantic Scholar
Long-term outcomes in patients with PET-predicted poor-responsive HER2-positive breast cancer treated with neoadjuvant bevacizumab added to trastuzumab and docetaxel: 5-year follow-up of the randomised Avataxher study
B. Coudert, J. Pierga, M. Mouret-Reynier, K. Kerrou +16 more
2020EClinicalMedicine9 citations Open access
Semantic Scholar
Evolution of Physical Status From Diagnosis to the End of First-Line Treatment in Breast, Lung, and Colorectal Cancer Patients: The PROTECT-01 Cohort Study Protocol
J. Mallard, E. Hucteau, R. Schott, T. Petit +13 more
2020Frontiers in Oncology8 citations Open access
Semantic Scholar
Agranulocytosis Induced by Tamoxifen in a Breast Cancer Patient
H. Herrscher, J. Leblanc, T. Petit
2019Breast Care8 citations Open access
Semantic Scholar
Can we establish a hierarchy among trastuzumab biosimilar candidates?
X. Pivot, T. Petit
2018British Journal of Cancer8 citations Open access
Semantic Scholar
Baseline quality of life and chemotherapy toxicities in patients with early breast cancer
I. Licaj, E. Coquan, T. Dabakuyo-Yonli, S. Dauchy +16 more
2023Cancer7 citations
Semantic Scholar
Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008-2016.
M. Frasca, Camille Sabathé, S. Delaloge, A. Galvin +21 more
2020European Journal of Cancer7 citations Open access
Semantic Scholar
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens
L. Cabel, M. Carton, B. Cheaib, J. Pierga +19 more
2018Breast Cancer Research and Treatment7 citations
Semantic Scholar
Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer.
L. Bender, C. Pflumio, P. Trensz, L. Pierard +3 more
2023Cancer Treatment and Research Communications6 citations Open access
Semantic Scholar
Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort
F. Moinard-Butot, C. Saint-Martin, C. Pflumio, M. Carton +20 more
2022Breast6 citations Open access
Semantic Scholar
Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer
C. Borel, O. Regnier-Gavier, H. Carinato, S. Guihard +15 more
2018OncoTarget6 citations Open access
Semantic Scholar
The Impact of an Incidental Dose on Axillary Tumor Control and Toxicity in Localized Breast Cancer: A Retrospective Analysis
M. Schmitt, I. Chambrelant, Parigna Hong Hong Chheang, C. Pflumio +3 more
2022Cancers5 citations Open access
Semantic Scholar
Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC Study
P. Heudel, S. Delaloge, D. Parent, N. Madranges +21 more
2020Anticancer Research5 citations Open access
Semantic Scholar
Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes
M. Carausu, M. Carton, V. Diéras, T. Petit +14 more
2022JAMA Network Open4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Gonçalves×27
Invite
A. Gonçalves — researcher profile on SciRah
F. Dalenc×27
Invite
F. Dalenc — researcher profile on SciRah
L. Uwer×25
Invite
L. Uwer — researcher profile on SciRah
J. Ferrero×24
Invite
J. Ferrero — researcher profile on SciRah

×24

Invite

C. Lévy — researcher profile on SciRah

M. Mouret-Reynier×23

Invite

M. Mouret-Reynier — researcher profile on SciRah

T. Bachelot×20

Invite

T. Bachelot — researcher profile on SciRah

Invite

M. Debled — researcher profile on SciRah

M. Leheurteur×16

Invite

M. Leheurteur — researcher profile on SciRah

Invite

P. Cottu — researcher profile on SciRah

A. Mailliez×14

Invite

A. Mailliez — researcher profile on SciRah

Invite

J. Eymard — researcher profile on SciRah